- Home
- Publications
- Publication Search
- Publication Details
Title
Antigenic evolution of SARS coronavirus 2
Authors
Keywords
-
Journal
Current Opinion in Virology
Volume 62, Issue -, Pages 101349
Publisher
Elsevier BV
Online
2023-08-28
DOI
10.1016/j.coviro.2023.101349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
- (2023) Can Yue et al. LANCET INFECTIOUS DISEASES
- Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
- (2023) Jessica Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
- (2023) Panke Qu et al. mBio
- Structural analysis of receptor engagement and antigenic drift within the BA.2 spike protein
- (2023) James W. Saville et al. Cell Reports
- Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1
- (2023) Anna Z Mykytyn et al. Lancet Microbe
- SARS‐CoV‐2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan‐coronavirus fusion inhibitors
- (2023) Shuai Xia et al. JOURNAL OF MEDICAL VIROLOGY
- Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
- (2023) Delphine Planas et al. Nature Communications
- SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
- (2023) Shuai Xia et al. Emerging Microbes & Infections
- In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
- (2023) Yuri Furusawa et al. EBioMedicine
- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
- (2022) Wilfredo F. Garcia-Beltran et al. CELL
- SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
- (2022) Wanwisa Dejnirattisai et al. CELL
- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
- (2022) Zhen Cui et al. CELL
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- (2022) Bo Meng et al. NATURE
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
- (2022) Kenrie P. Y. Hui et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- (2022) Rigel Suzuki et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
- (2022) Annika Rössler et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
- (2022) Dhiraj Mannar et al. SCIENCE
- Cryo-EM structure of the SARS-CoV-2 Omicron spike
- (2022) Gabriele Cerutti et al. Cell Reports
- Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients
- (2022) Corine H. GeurtsvanKessel et al. Science Immunology
- In silico analysis of mutations near S1/S2 cleavage site in SARS‐CoV‐2 spike protein reveals increased propensity of glycosylation in Omicron strain
- (2022) Christopher A. Beaudoin et al. JOURNAL OF MEDICAL VIROLOGY
- Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
- (2022) Matthew McCallum et al. SCIENCE
- SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
- (2022) Sabrina Lusvarghi et al. Science Translational Medicine
- Mutations and Evolution of the SARS-CoV-2 Spike Protein
- (2022) Nicholas Magazine et al. Viruses-Basel
- Evolution of the SARS-CoV-2 spike protein in the human host
- (2022) Antoni G. Wrobel et al. Nature Communications
- Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
- (2022) Yang Liu et al. Cell Reports
- Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
- (2022) Nell Saunders et al. EBioMedicine
- Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
- (2022) Wan-Ling Wu et al. JCI Insight
- SARS-CoV-2 spike E156G/Δ157-158 mutations contribute to increased infectivity and immune escape
- (2022) Tarun Mishra et al. Life Science Alliance
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
- (2022) Aekkachai Tuekprakhon et al. CELL
- Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
- (2022) Chiara Pastorio et al. Cell Host & Microbe
- Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
- (2022) Karlijn van der Straten et al. IMMUNITY
- Will ‘Centaurus’ be the next global coronavirus variant? Indian cases offers clues
- (2022) Ewen Callaway NATURE
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
- (2022) Qian Wang et al. NATURE
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
- (2022) Nicole P. Hachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
- (2022) Jun Siong Low et al. SCIENCE
- Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
- (2022) Meriem Bekliz et al. Nature Communications
- Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
- (2022) Xiaoyu Sun et al. Nature Microbiology
- A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant
- (2022) Man Chun Chiu et al. Cell Discovery
- Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
- (2022) Anna Z. Mykytyn et al. Science Immunology
- Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5
- (2022) Chee-Wah Tan et al. Lancet Microbe
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
- (2022) Izumi Kimura et al. CELL
- Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
- (2022) Akatsuki Saito et al. Cell Host & Microbe
- Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
- (2022) Yunlong Cao et al. Cell Host & Microbe
- Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
- (2022) Panke Qu et al. Cell Host & Microbe
- Antigenic cartography of well-characterized human sera reveal differences in neutralizing capacity based on infection and vaccination history
- (2022) Wei Wang et al. Cell Host & Microbe
- Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
- (2022) Qian Wang et al. Cell Host & Microbe
- Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
- (2022) Bingjie Hu et al. Emerging Microbes & Infections
- SARS-CoV-2 Omicron variant emerged under immune selection
- (2022) Chee Wah Tan et al. Nature Microbiology
- Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
- (2022) Kenrie P.Y. Hui et al. EBioMedicine
- Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
- (2022) Alexander Muik et al. Science Immunology
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
- (2022) Qian Wang et al. CELL
- BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
- (2022) Annika Rössler et al. Nature Communications
- A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
- (2022) Jiandong Huo et al. Cell Reports
- Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
- (2022) Xue-Jun Wang et al. Genome Medicine
- Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
- (2021) Zhuoming Liu et al. Cell Host & Microbe
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
- (2021) Allison J. Greaney et al. Cell Host & Microbe
- Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite
- (2021) Gabriele Cerutti et al. Cell Host & Microbe
- SARS-CoV-2 spike D614G change enhances replication and transmission
- (2021) Bin Zhou et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
- (2021) Xuping Xie et al. NATURE MEDICINE
- The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
- (2021) Priyanka Shah et al. Frontiers in Immunology
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
- (2021) Matthew McCallum et al. CELL
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
- (2021) Xiaoying Shen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
- (2021) Jianying Liu et al. NATURE
- Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
- (2021) Sophie M.-C. Gobeil et al. SCIENCE
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
- (2021) Bo Meng et al. Cell Reports
- N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
- (2021) Fang Tian et al. eLife
- Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
- (2021) Cecylia S. Lupala et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
- (2021) Maaran Michael Rajah et al. EMBO JOURNAL
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
- (2021) Akatsuki Saito et al. NATURE
- Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
- (2021) Keiya Uriu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 spreads through cell-to-cell transmission
- (2021) Cong Zeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
- (2021) Jun Zhang et al. SCIENCE
- SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity
- (2021) Sabari Nath Neerukonda et al. Viruses-Basel
- Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding
- (2021) Dhiraj Mannar et al. Cell Reports
- Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus
- (2021) Fatima Amanat et al. PLOS BIOLOGY
- SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
- (2021) Hanjun Zhao et al. Emerging Microbes & Infections
- Cross-Species Transmission of Coronaviruses in Humans and Domestic Mammals, What Are the Ecological Mechanisms Driving Transmission, Spillover, and Disease Emergence?
- (2021) Nicole Nova Frontiers in Public Health
- Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike
- (2021) Bailey Lubinski et al. iScience
- Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
- (2020) Sufang Tian et al. Journal of Thoracic Oncology
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States
- (2020) Joseph R. Fauver et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
- (2020) Drew Weissman et al. Cell Host & Microbe
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
- (2012) Taylor Heald-Sargent et al. Viruses-Basel
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now